These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 19197550)
21. Polyserositis as a manifestation of graft-versus-host disease. Khalil A; Ben Barak A; Zaidman I; Elhasid R; Rowe JM; Ben-Arush M Pediatr Hematol Oncol; 2011 Nov; 28(8):691-3. PubMed ID: 22023464 [No Abstract] [Full Text] [Related]
22. Erythema multiforme-like presentation of chronic graft versus host disease. Doherty C; Ulitsky O; Petronic-Rosic V J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S127-8. PubMed ID: 19119127 [No Abstract] [Full Text] [Related]
23. Lack of efficacy of rituximab in refractory sclerodermatous chronic GVHD. George L; George B; Gottlieb DJ; Hertzberg M; Fernandez-Peñas P Bone Marrow Transplant; 2012 May; 47(5):737-8. PubMed ID: 21785472 [No Abstract] [Full Text] [Related]
24. Scleromalacia perforans complicating graft-versus-host disease. Hon C; Law RW; Au WY Br J Haematol; 2005 Apr; 129(1):1. PubMed ID: 15801949 [No Abstract] [Full Text] [Related]
25. The histopathology of graft-versus-host disease. Farmer ER Adv Dermatol; 1986; 1():173-88. PubMed ID: 3079242 [No Abstract] [Full Text] [Related]
27. A case of severe sclerodermatous chronic graft-versus-host disease: exposure to cement containing abundant silica may have been a relevant factor in scleroderma-like skin changes. Uenishi T; Sugiura H J Dermatol; 2005 May; 32(5):413-5. PubMed ID: 16043910 [No Abstract] [Full Text] [Related]